| Image |
No pdb structure |
| GO Annotations |
Cellular Component |
|
| Molecular Function |
|
| Biological Process |
|
| Pathways |
|
| Drugs |
|
| Diseases |
|
| GWAS |
- Adverse response to drug ( 30420678)
- Blood metabolite levels ( 24816252)
- Blood metabolite ratios ( 24816252)
- Glycerophospholipid levels ( 26068415)
- Metabolic traits ( 21886157)
- Metabolite levels ( 22916037)
- Phospholipid levels (plasma) ( 22359512)
- Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid) ( 21829377)
- Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid) ( 21829377)
- Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid) ( 21829377)
- Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid) ( 24823311)
- Red blood cell fatty acid levels ( 25500335)
- Response to (pegylated) interferon in HBeAg-negative hepatitis B ( 30715261)
- Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1) ( 26503814)
- Serum metabolite ratios in chronic kidney disease ( 29545352)
|
| Interacting Genes |
4 interacting genes:
FXYD6
IFITM3
MALL
TMEM218
|
| Entrez ID |
54898 |
| HPRD ID |
16857 |
| Ensembl ID |
ENSG00000197977
|
| Uniprot IDs |
A0A024QZV3
Q9NXB9
|
| PDB IDs |
|
| Enriched GO Terms of Interacting Partners? |
|
| Tagcloud ? |
|